Skip to main content
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: Neuropharmacology. 2011 Aug 4;62(1):313–321. doi: 10.1016/j.neuropharm.2011.07.040

Figure 2.

Figure 2

IL-1β administration led to significant body weight reductions. DMP904 did not ameliorate this effect. Animals were weighed and injected at the same time daily for six consecutive days.